Business
BELLUS Health to present at the Rodman and Renshaw 5th Annual Global Healthcare Conference
Presentation will be Web cast live LAVAL, QC, May 15 /CNW Telbec/ - BELLUS Health Inc. (NASDAQ: B...
About this update from Bluenergies Ltd.
[{"type":"text","content":"\n\n\n\nPresentation will be Web cast live\n\n\nLAVAL, QC, May 15 /CNW Telbec/ - BELLUS Health Inc. (NASDAQ: BLUS; TSX:\nBLU, formerly known as Neurochem Inc.) announces today that on Monday, May 19,\n2008, Dr. Francesco Bellini, BELLUS Health's Chairman, President and Chief\nExecutive Officer will present BELLUS Health's strategy at the Rodman and\nRenshaw 5th Annual Global Healthcare Conference to be held at the Le Meridien\nBeach Plaza Hotel Monte Carlo, Monaco. The presentation will take place at\n11:05 A.M. CEST (05:05 A.M. EDT).\n\n\nThe live Web cast of BELLUS Health's presentation (audio and visual) can\nbe accessed at http://www.wsw.com/webcast/rrshq13/blus/. A replay of the\npresentation will begin three (3) hours after the actual presentation time,\nand will be available until May 26, 2008. Please access the Web cast\napproximately 15 minutes before the presentation is scheduled to begin.\n\n\nAbout BELLUS Health\n\n\nBELLUS Health is a global health company focused on the development and\ncommercialization of products to provide innovative health solutions to\naddress critical unmet medical needs.\n\n\nTo Contact BELLUS Health\n\n\nFor additional information on BELLUS Health and its programs, please call\nthe Canada and United States toll-free number 1-877-680-4500 or visit the Web\nSite at www.bellushealth.com.\n\n\nCertain statements contained in this news release, other than statements\nof fact that are independently verifiable at the date hereof, may constitute\nforward-looking statements. Such statements, based as they are on the current\nexpectations of management, inherently involve numerous risks and\nuncertainties, known and unknown, many of which are beyond BELLUS Health\nInc.'s (formerly known as Neurochem Inc.) control. Such risks include but are\nnot limited to: the impact of general economic conditions, general conditions\nin the pharmaceutical and/or nutraceutical industry, changes in the regulatory\nenvironment in the jurisdictions in which the BELLUS Health group does\nbusiness, stock market volatility, fluctuations in costs, and changes to the\ncompetitive environment due to consolidation, that actual results may vary\nonce the final and quality-controlled verification of data and analyses has\nbeen completed, as well as other risks disclosed in public filings of BELLUS\nHealth Inc. Consequently, ac...